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Introduction: Endograft infection has received less attention than other complication, so that little is
known about the general features, risk factors, and treatment. The purpose of this short series is to
examine our experience of infective complications after EVAR.
Material and methods: Between November 2000 and December 2008, 247 patients underwent endograft
repair for abdominal aortic aneurysm. Follow-up protocol included clinical visit and computed-tomog-
raphy angiography 1, 4 and 12 months after the intervention, and yearly thereafter. No duplex control
was performed on a regular basis.
Results: Median follow-up was 16 months (range, 3e92); two patients (2/244, 0.8%) developed an
endograft infection, 12 and 36-months after the intervention respectively. On admission, both patients
complained septic-like fever and abdominal discomfort; leukocytes-labelled scans did not reveal path-
ologic traits whereas spiral computed-tomography conﬁrmed the suspicious of endograft infection. They
underwent endograft removal and extra-anatomic axillo-bifemoral by-pass; both survived and are still
alive 12 and 6-months after the intervention. Isolated micro-organisms were Candida albicans and
Escherichia coli in one patient, and Haemophilus aphrophilus in the other.
Conclusion: Endograft infection is an uncommon occurrence, Spiral computed-tomography seems to be
an essential diagnostic tool. Graft removal was successful in our high-risk patients. A multicenter registry
should be started to deﬁne guidelines.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Endograft (EG) infection has received less attention than
conventional graft infection, because most endovascular aortic
repair (EVAR) surveillance concentrated on the technical aspects of
the procedure, including endoleaks, device migration, neck dilata-
tion, and rupture.1 Therefore, up to date little is known about the
general features and potential risk factors of aorto-iliac EG infec-
tion, and treatment is still being undertaken on a case-by-case
basis.1,2 However, since the ﬁrst ever report in 1993,3 a growing
number of cases appeared in literature.4e16 The purpose of this
short series is to report 2 cases of EG infection of our endovascular
experience after EVAR.lian Society of Vascular and
e30th, 2009.
x: þ39 0332 278.581.
. Piffaretti).
ciates Ltd. Published by Elsevier Lt2. Materials and methods
All cases of elective or emergency EVAR for abdominal aortic
aneurysm (AAA). were collected into a speciﬁc database All but 5
interventions (2%) were performed in the operating theater.
Generally, our patients received general anesthesia with oro-
tracheal intubation. Intravenous (i.v.) short-term antibiotic
prophylaxis was always administered (vancomycin 2 g b.i.d.) at the
beginning of the anesthesia. We generally used a bilateral femoral
approach through a surgical approach performed in standard
fashion. Brachial access was never used. Patients undergoing EVAR
were followed-up in the vascular clinics 1, 4, and 12 months after
the intervention, and yearly thereafter. At each visit, patients
underwent contrast-enhanced spiral computed-tomography (CT)
scan. More recently, contrast-enhanced ultrosound evaluation of
the endografts was used selectively. All deaths were identiﬁed
through the hospital system, or the general practitioner using
a phone call. Between November 2000 and December 2008, 247
patients underwent EG repair for AAA. Median follow-up of 16
months (range, 3e92); 42 patients (18.6%) died, and 2 patientsd. All rights reserved.
G. Piffaretti et al. / International Journal of Surgery 8 (2010) 216e220 217(4/244, 0.8%) developed an EG infection. The diagnosis of EG
infection was generally evaluated or ruled out using a combination
of clinical visit, bioumoral proﬁles, labelled leukocytes-scans, CT
scans, and microbiology cultures. Collected data included age,
gender, co-morbidities deﬁned accordingly to the Society for
Vascular Surgery (SVS) score,17 prophylactic antibiotic regimen,
type of EG used, adjunctive endovascular procedures, presentation
of sepsis, time interval between EVAR and EG infection, type of
treatment and operative features, complications, isolated micro-
organisms with subsequent antibiotic/anti-mycotic therapies and
their duration, follow-up with the ultimate outcome. Table 1
summarizes the clinical proﬁles of the 2 EG infections.2.1. Case report #1
He was a 69-years old male patient. Medical history comprised
hypertension, ischemic heart disease, and chronic obstructive
disease; also, he had left lobe lung resection for a benign pathology.
Vascular surgical history began with an elective endovascular
exclusion of an aorto-bi-iliac aneurysm treatedwith a bifurcated EG
(Excluder-W.L. Gore & Ass., Flagstaff-AZ, USA). During tne follow-
up, the patient was discovered to have a type II endoleak coming
from a patent inferior mesenteric artery, and from a bilateral
hypogastric aneurysm both treated by simple overstentng during
the previous endovascular procedure. We initially scheduled
a laparoscopic ligation of the patent inferior mesenteric artery, and
while attempting to ligate also the left hypogastric aneurysm it
ruptured and wewere forced to convert the procedure to a midline
laparotomy, resection and ligation of the left iliac endograft and
common iliac vein because of an unmanageable bleeding forTable 1
Patients' details with endograft-related sepsis after EVAR.
Patient # 1 Patient # 2
Age, (yrs) 69 62
Gender Male Male
Co-morbidities
IHD yes yes
COPD yes no
CRF no yes
Previous
vascular surgery
EVR; FF bp renal artery
PTA-stent; EVR
SVS score, (#) 6 7
Urgency no no
Presentation
Temperature, (C) 38.2 38
WBC count, (cells/mm3) 14.240 12.280
SV, (mm/h) 112 99
C-rp, (mg/L) 23.1 66
Originary intervention
Aortic lesion A.A.A. A.A.A.
Type of EG bifurcated infrarenal
(2nd Excluder)
bifurcated infrarenal
(2nd Excluder)
Adjunctive EVR no no
Infection delay,
(months)
13 38
Treatment EG removal þ AxbF bp þ
ﬁstula excision
EG removal þ AxbF bp þ
jejunal suture
Offending
micro-organism
Escherichia
and Candida albicans
Haemophilus aphrophilus
Complication axillary hematoma no
Antibiotics
consolidation, (time)
ciproﬂoxacin and
ﬂuconazol, 2 omnths
ceftriaxon, 4 weeks
Outcome alive alive
Follow-up, (months) 20 12
IHD ¼ ischemic heart disease; COPD ¼ chronic obstructive pulmonary disease;
CRF ¼ chronic renal failure.
AbF ¼ aorto-bifemoral; bp ¼ by-pass; FF ¼ femoro-femoral bp; WBC ¼white blood
cell; SV ¼ sedimentation velocity; C-rp ¼ C-reactive protein; EG ¼ endograft.
EVR ¼ endovascular; AxbF ¼ axillo-bifemoral.a iatrogenic injury of this vein, with subsequent right-to-left fem-
oro-femoral by-pass with a bioactive 8-mm armed ePTFE (Prop-
aten-W.L. Gore & Ass., Flagstaff-AZ, USA) graft. Postoperatively, he
was transferred in the intensive care unit and needed protracted
oro-tracheal intubation (13 days). The patient was then discharged
uneventful and asymptomatic on day 25th. Twenty-four months
after EVAR, he developed septic-like fever associated with back-
ache: a CT-scans revealed air inclusions in the thrombosed aortic
sac, and a ﬂuid collection around the right iliac arteries (Fig. 1AeC).
Intervention included re-do laparotomy, EG removal using supra-
renal clamping, drain of the aneurysm sac, direct closure of the
aortic stump, resection of a small jejunal tract (w20 cm) that was
noted to present wall erosion without clear signs of an enteric
ﬁstula, and a bioactive 8-mm armed ePTFE (Propaten-W.L. Gore &
Ass., Flagstaff-AZ, USA) right axillo-to-prosthetic graft by-pass.
Intraoperative cultures coming from the sac and the EG specimen
were positive for Escherichia coli and Candida albicans: anti-mycotic
therapy (B-amphotericin) and speciﬁc antibiotics (meropenem)
were used for 21 days Intensive care unit stay was remarkable for
a right axillary hematoma that required re-exploration. He was
commenced on oral antibiotics regimen (ﬂuconazol and cipro-
ﬂoxacin) on day 45 prolonged for two months. He was last seen 20-
months later, asymptomatic.
2.2. Case report #2
This is the case of a 62-years old male patient known for elective
EVAR. Medical history comprised hypertension, ischemic heart
disease, and chronic renal failure treated by renal stentin, bilaterally;
surgical interventions included coronary-artery by-pass graft. In
addition, one year before his re-admission, he was recovered for an
episode of acute sigmoid diverticulitis: conservative treatment with
parenteral nutrition and wide-broad spectrum antibiotics was
successful. Thirty-six months after EVAR (bifurcated Excluder-W.L.
Gore & Ass., Flagstaff-AZ, USA), he developed intermittent fever and
rightﬂankpain for fourdays.Urineandbloodcultureswerenegative;
leukocytes-labelled scans were aspeciﬁc (Fig. 2A), but ultrasonog-
raphy showed a ﬂuid collection in the right pelvis. A CT-scan control
revealed a right abscess around the psoas muscle conditioning
hydronephrosis (Fig. 2B), and thepresenceof a type1aendoleakwith
a suspect distal migration of the EG that the same examination per-
formed during the evaluation of the previously cited acute divertic-
ulitis did not highlighted. We decided to start with an exploratory
laparoscopy that showed the perforation of the appendix; therefore,
appendectomy and drainage of the abscess were performed. Intra-
operative cultureswere sterile. Postoperative course continued to be
suggestive for sepsis, since day6th fromappendectomy: owing to his
known chronic renal insufﬁciency, we carried out a magnetic-
reseonance angiography (MR-A) that revealed air inclusions in the
sac as well as conﬁrmed the proximal endoleak (Fig. 2C). Hence,
although the high operative risk, we removed the EG (suprarenal
clamping), drained the aneurysm sac, closed the aortic stump, and
revascularized the lower limbs with a silver-bonded 8-mm dacron
(Silver graft-Braun, Melsungen-Germany) axillo-bifemoral by-pass
graft. Intraoperative cultures were positive for Haemophilus aphro-
philus. Speciﬁc antibiotic therapy (ceftriaxon) was used for four
weeks; the patient did well, and was discharged on day 18; he was
last seen 12-months later, asymptomatic.
3. Discussion
Recently an increasing number of case reports or short series
have been published on EG infection.1e15 In their study, Ducasse
et al.1 reported the result of a survey on a multicenter experience of
9739 EVAR procedures and found 42 cases of EG infection for an
Fig. 1. Preliminary CT-angiography shows air inclusion in the native aneurysmatic sac (A) without direct signs of enteric ﬁstulization (arrow), exclusion of the previous endoleak
with the clips at the origin of the inferior mesenteric artery (B, ring), and the ﬂuid collection surrounding the sac and iliac branches (C).
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would indicate that EGs seemed to have a lower infection rate than
that of conventional grafts (range 0.5e3%), but it should be pointed
out that the result of multiple factors such as the shorter follow-up
of EVAR procedures, and the lack of larger series of EG infection
might underscore the real incidence rate of this complication.2 In
our experience, all patients treated with an EG for abdominal aortic
aneurysm entered in the follow-up protocol, and 83% are still
available for surveillance: this could be one of the reason why EG
infection rate was higher in our experience, accounting for 0.8% of
all endovascular aortic aneurysm repair.Fig. 2. Leukocytes-labelled scans after the episode of diverticulitis did not show speciﬁc ﬁnd
the psoas muscle conﬁguring a typical abscess (B, squared ring and arrows). MR-angiography
the native aneurysmatic sac (arrow) and the presence of a type 1a endoleak (C, sketched arAlthough many infections occur from contamination at the time
of placement, secondary infection can occur from remote sources,
or hematogenous seeding, or mechanical erosion.1,4,6 Reports have
documented the development of EG infection in the presence of
other infective source, for example, in the urinary tract.8 In addi-
tion, patients with a history of chronic bowel disease suggested the
possibility of bacterial translocation with eventual EG seeding.9 In
particular, in one of our cases, a secondary infection from a remote
source could not be ruled out since the potential superinfection of
the EG could have been resulted from the complicated appendicitis
or following a previous episode of acute diverticulitis. In the otherings of EG infection (A). CT-angiography conﬁrmed the presence of ﬂuid collection into
conﬁrmed the suspicious of EG infection showing air inclusion at the upper portion of
row).
Table 2
Primary endograft infection: literature main data.
Author, yr # Cases Risk
factors
Prophylaxis Suite Post-EVR
intervention
Endograft
(manufacturer)
Latency
(months)
Symptoms X-rays-
examinations
Preopertive
drainage
(yes/no)
Reconstruction
(type and
materials)
Complication Pathogen P.op therapy
(duration)
Follow-up
(months)
Chalmers, 93 1 no
Baker, 02 1 no n.s. n.s. no Talent 12 fever nuclear scans
(CT negative)
yes extra-
anatomic
(ePTFE)
no Enterococcus levoﬂoxacin
þ metronidazol
(4 weeks)
6: alive
Mueller, 03 1 foot
gangrene
colorectal
cancer
cefazolin radiology no Ancure 0.3 fever 2 CT þ
nuclear scans
(ﬁrst CT
negative)
yes extra-
anatomic
(n.s)
no St. aureus ciproﬂoxacine
þ
meropenem
þ vancomycin
(n.s.)
n.s.
Pringle, 03 1 CVC
infection
n.s. n.s. no Excluder 0.3 fever CT þ
nuclear scans
no extra-
anatomic
(n.s.)
no MRSA n.s. 24: alive
Karamlou, 04 1 no n.s. n.s. no AneuRx 12 fever
abdominal pain
2 CT þ
nuclear scans
(ﬁrst CT
negative)
no in situ
(homograft)
M.O.F. MRSA n.s. 0.5: dead
Parra, 04 1 no cefazolin n.s. no AneuRx 24 abdominal pain CT no extra-
anatomic (n.s.)
no n.s. n.s. (6 weeks) 12: dead
Silberfein, 06 1 foot
cellulitis
n.s. n.s. no Excluder 28 lynphoadenomegaly CT no extra-
anatomic
(dacron)
no Pastourella
multocida
ciproﬂoxacin
þ piperacillin/
tazobactam
(ciproﬂoxacin,
6 months)
6: alive
Ghosh, 06 1 no n.s. n.s. no AneuRx 9 fever
lumbar pain
n.s. no not operated
(extensive
colonic
ischemia)
exitus n.s.
de Bast, 06 1 no n.s. n.s. no Zenith 8 fever
lumbar pain
CT no in situ
(homograft)
no MSSA oxacillin þ
riphampicin
þ vancomycin
(n.s.)
6: alive
Bakoyiannis,
06
1 no vancomycin radiology no AneuRx 36 fever CT no in situ
(dacron
riphampicin-
impregnated)
M.O.F. Candida
albicans
n.s. 0: dead
Hulin, 07 1 no n.s. n.s. endoleak
embolization
n.s. 24 fever
lumbar pain
CT yes
(Wallace)
no St. oralis
& mitis
riphampicin
(3 months)
24: alive
Sharif, 07 6 IBD (1), cefuroxime n.s. endoleak
embolization
Zenith (4) 17.6 psoas abscess (2) CT (6) yes (2) extra-
anatomic (3)
exitus (2) Prop.
avium (1)
n.s. 23.4
diabetes (2) teicoplanine Talent (2) AE ﬁstula (2) (n.s.) ARF (1) St. aureus (1) (alive 2,
dead 1)
septic shock (")
Saleem, 08 1 diabetes n.s. n.s. no Zenith 6.5 fever
lumbar pain
CT yes not operated
(no further
symptoms)
no Listeria
monocytogenes
cotrimoxazol þ
amoxicillin
(6 months)
19: alive
present, 09 2 acute
diverticulitis
vancomycin theatre femefem
by-pass
Excluder 25.5 fever (2) CT (2) no extra-
anatomic
no Haemophilus
aphrophilus
ceftriaxon
(4 weeks)
16
lumbar pain (1) (1 CT
negative)
(1 dacron silver-
impregnated)
E. coli þ Candida
albicans
ciproﬂoxacine
þ ﬂuconazol
(2 months)
(alive 2)
psoas abscess (1) (1 nuclear
scan negative)
(1 ePTFE)
CVC: central venous cathter; IBD: inﬂammatory bowel disease; AF: aorto-enteric ﬁstula; CT: computed-tomography; M.O.F.: multi organ failure; ARF: acute renal failure; MSSA: methicillin-sensitive Staphylococcus aureus; MRSA:
methicillin-resistant Staphylococcus aureus; Prop. avium: Propiobacterium avium; E. coli: Escherichia coli.
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to progressive erosion of the bowel wall and secondarily to
contamination of the EG. In addition, studies of patients under-
going open repair have shown the presence of bacteria in aortic
thrombus. The presence of an endoleak may contribute to possible
hematogenous seeding and infection of the EG.11,15 Although any
association between endoleak and EG infection should be consid-
ered speculative, in one of our case a large type 1 endoleak was
detected during the follow-up to be present at the time we made
the diagnosi of EG infection.
For both open repair and EGs, radiologic studies are an impor-
tant adjunct in the diagnosis of infection. An abdominal CT scan
should be the initial test to conﬁrm or exclude a suspicious of EG
infection, as it usually reveals typical inﬂammatory changes or ﬂuid
surrounding the graft, or even gas within the native aneurysm sac.
In our experience, as well as occurred in 15% (3/20 cases) of primary
EG infectionwe found in the Literature, CT was initially negative for
these signs4,6,10 (Table 2). Additionally, although the leukocytes-
labelled scan could provide additional information, in one of our
cases it resulted in aspeciﬁc ﬁndings. In contrast, previous reports
suggested that gadolinium-enhanced MR-A may.7 Our experience
was consistent with this ﬁnding since MR-A was helpful to deﬁne
EG infection in the case CT failed.
In the survey of Ducasse et al.1 although the difference was not
statistically signiﬁcant, mortality was higher after conservative treat-
ment than after surgical treatment; in the study of Sharif et al.,2 50% of
the patientswithout EG removal died.Moreover, overallmortalitywas
reported to be satisfactory in comparisonwithmortality reported after
open repair for conventional graft infection.1,18e21 We are in accor-
dancewith the dogmatic view that an infected graft should always be
completely removed: in our experience, EG removal seemed the only
chance to survive for the patient, even if the operative risk was very
high owing to the important co-morbidities.
An important issue to be pointed out is technical strategy to
treat EG infection: though in situ replacement has been reported to
provide signiﬁcantly better results in terms of patency and infec-
tion reappearance, out of the twenty cases of piled up in our brief
but speciﬁc review of primary EG infection, the most frequent
surgical reconstruction performed was the excision of the aortic
graft with an extra-anatomical revascularization reporting
encouraging results than those obtained for the treatment of
conventional graft infection.1,2,12 However, a note of caution should
be mandated because of the short mean follow-up.
The most frequent causative organism described in the
conventional surgery series was Staphylococcus species, as simi-
larly occurred in the largest review available so far. However, with
respect to the cause of our infections, the presence of bowel ﬂora
in blood and specimen cultures should be always considered,
especially for those patient with aorto-enteric ﬁstulas or initial
erosions of the bowel wall.2,5,11,14 Despite fungal infection of an
aorto-iliac EG has been rarely described, C. albicans was isolated
from the intraoperative ﬁeld in combination with other agents.
These ﬁndings should be emphasized because no current guide-
lines exist on the exact type and duration of the antibiotic treat-
ment in this situation; our strategy was based on expert
consensus involving local authorities, who also established the
type and eventual multi-agent therapy, as far as the consolidation
period.
4. Conclusion
Our experience is consistent with previous data, conﬁrming that
aorto-iliac EG infection was an unusual occurrence. Nevertheless,as more patients will be treated by endovascular technique,
a greater attention should be posed to intercept this challenging
complication.
We believe that the most effective treatment consisted of
complete EG removal; conservative treatment should be probably
reserved to those patient at deemed high operative risk.
A multicenter registry should be started to obtain the necessary
data to deﬁne optimal diagnostic and therapeutic guidelines.
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